CANQF
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Aug 1 closing price
Capitalization
212.11K
CHSYF
Price
$1.35
Change
-$0.17 (-11.18%)
Updated
Aug 1 closing price
Capitalization
4.13B
Interact to see
Advertisement

CANQF vs CHSYF

Header iconCANQF vs CHSYF Comparison
Open Charts CANQF vs CHSYFBanner chart's image
CanaQuest Medical
Price$0.01
Change-$0.00 (-0.00%)
Volume$95K
Capitalization212.11K
China Medical System Holdings
Price$1.35
Change-$0.17 (-11.18%)
Volume$1K
Capitalization4.13B
CANQF vs CHSYF Comparison Chart in %
Loading...
CANQF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CANQF vs. CHSYF commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANQF is a Hold and CHSYF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (CANQF: $0.01 vs. CHSYF: $1.35)
Brand notoriety: CANQF and CHSYF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CANQF: 506% vs. CHSYF: 59%
Market capitalization -- CANQF: $212.11K vs. CHSYF: $4.14B
CANQF [@Pharmaceuticals: Generic] is valued at $212.11K. CHSYF’s [@Pharmaceuticals: Generic] market capitalization is $4.14B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $66.04B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANQF’s FA Score shows that 0 FA rating(s) are green whileCHSYF’s FA Score has 1 green FA rating(s).

  • CANQF’s FA Score: 0 green, 5 red.
  • CHSYF’s FA Score: 1 green, 4 red.
According to our system of comparison, CHSYF is a better buy in the long-term than CANQF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CANQF’s TA Score shows that 1 TA indicator(s) are bullish while CHSYF’s TA Score has 1 bullish TA indicator(s).

  • CANQF’s TA Score: 1 bullish, 5 bearish.
  • CHSYF’s TA Score: 1 bullish, 3 bearish.
According to our system of comparison, CHSYF is a better buy in the short-term than CANQF.

Price Growth

CANQF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while CHSYF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.48%. For the same industry, the average monthly price growth was +8.38%, and the average quarterly price growth was +79.14%.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.48% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHSYF($4.13B) has a higher market cap than CANQF($212K). CHSYF YTD gains are higher at: 45.052 vs. CANQF (-50.000).
CANQFCHSYFCANQF / CHSYF
Capitalization212K4.13B0%
EBITDAN/AN/A-
Gain YTD-50.00045.052-111%
P/E RatioN/A14.53-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CANQF vs CHSYF: Fundamental Ratings
CANQF
CHSYF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
15
Undervalued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
10039
PRICE GROWTH RATING
1..100
9237
P/E GROWTH RATING
1..100
10075
SEASONALITY SCORE
1..100
5055

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHSYF's Valuation (15) in the null industry is in the same range as CANQF (36). This means that CHSYF’s stock grew similarly to CANQF’s over the last 12 months.

CHSYF's Profit vs Risk Rating (94) in the null industry is in the same range as CANQF (100). This means that CHSYF’s stock grew similarly to CANQF’s over the last 12 months.

CHSYF's SMR Rating (39) in the null industry is somewhat better than the same rating for CANQF (100). This means that CHSYF’s stock grew somewhat faster than CANQF’s over the last 12 months.

CHSYF's Price Growth Rating (37) in the null industry is somewhat better than the same rating for CANQF (92). This means that CHSYF’s stock grew somewhat faster than CANQF’s over the last 12 months.

CHSYF's P/E Growth Rating (75) in the null industry is in the same range as CANQF (100). This means that CHSYF’s stock grew similarly to CANQF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CANQFCHSYF
RSI
ODDS (%)
Bullish Trend 5 days ago
50%
Bearish Trend 4 days ago
40%
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
11%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
14%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
18%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
43%
Bullish Trend 4 days ago
9%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
9%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CANQF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBAI7.140.53
+8.02%
BigBearai Holdings
AROW27.470.92
+3.47%
Arrow Financial Corp
ENTX1.820.02
+1.11%
Entera Bio Ltd
PAA17.86-0.01
-0.06%
Plains All American Pipeline LP
PW1.35-0.01
-1.09%
Power REIT

CANQF and

Correlation & Price change

A.I.dvisor tells us that CANQF and CRLBF have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CANQF and CRLBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANQF
1D Price
Change %
CANQF100%
N/A
CRLBF - CANQF
16%
Poorly correlated
+9.79%
CNTMF - CANQF
15%
Poorly correlated
+11.48%
CAIHF - CANQF
0%
Poorly correlated
N/A
CHSYF - CANQF
-0%
Poorly correlated
N/A
CBWTF - CANQF
-4%
Poorly correlated
-0.91%
More

CHSYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHSYF has been loosely correlated with CNADF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CHSYF jumps, then CNADF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHSYF
1D Price
Change %
CHSYF100%
N/A
CNADF - CHSYF
38%
Loosely correlated
N/A
SBFM - CHSYF
30%
Poorly correlated
N/A
SXTC - CHSYF
23%
Poorly correlated
+0.63%
TKNO - CHSYF
22%
Poorly correlated
-2.53%
CANN - CHSYF
7%
Poorly correlated
-44.24%
More